Comparing Palliative Radiotherapy With or Without Carboplatin

Summary

The study population has locally advanced or metastatic bronchial or head and neck cancer. This study assesses the value of concomitant chemo/radiotherapy with carboplatin daily during metastatic radiotherapy versus radiotherapy alone. The realization of a systemic treatment during the radiotherapy could make it possible to obtain a benefit on the control of the evolution of the metastases and thus of the pains generated, as well as on the quality of life of the patients. In addition, a benefit in overall survival is possible.

Timeline

Start

2015-08-17

Primary completion

2017-11-28

Completion

2018-05-28

Outcome

Outcome not reported

Stopped (Enrollment): “The study was stopped due to insufficient recruitment.”

Drugs

Indications